XiFin to Highlight Impact of FDA Regulations, Other Disruptive Forces Facing Hospitals, Independent Labs, and Pathology Practices at 29th Annual Executive War College
23 Abril 2024 - 10:01AM
Business Wire
XiFin Executive Chair and CEO Lâle White
Keynote to Kick Off General Speaking Sessions As Industry Prepares
for Critical Policy Changes
XiFin, Inc., a leading provider of innovative healthcare
information technologies and services that deliver artificial
intelligence (AI)-enabled operational efficiency, interoperability,
and simplicity, will showcase forward-thinking insights, speaking
at four sessions and two panels at the 29th Annual Executive War
College on Diagnostics, Clinical Laboratory, and Pathology
Management conference. Leveraging insights on big data gleaned from
its experienced team of industry leading executives and
award-winning platform, XiFin leaders plan to drive strategic,
financial, and operational discussions.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240423862318/en/
XiFin Speakers: On left, Lâle White. From
top left to right, Diana Richard, Stephanie Denham, Jeff
Carmichael, Sandra Greefkes, Heather Agostinelli, and Clarisa
Blattner. (Photo: Business Wire)
XiFin Executive Chair and CEO Lâle White will deliver a keynote
focusing on the new regulations and market forces that will impact
the diagnostic industry. Chief among these is the FDA’s bid for
control of laboratory-developed tests (LDTs) and concerns
surrounding Medicare Advantage programs. White aims to provide a
grounding on these and other challenges to help attendees navigate
the policy environment as they make institutional decisions in the
coming year.
In addition, XiFin will share its new White Paper “Guide to
AI-Enabled Revenue Cycle Management for Molecular Diagnostics and
Pathology Practices” with all attendees. This paper demonstrates
XiFin’s unique approach to facilitating organizational transition
from complexity to clarity through AI-enabled workflows, which
improve operational and financial performance, allowing customers
to expand their impact in a timely manner. Furthermore, XiFin will
reaffirm its commitment to innovation, expertise, and advocacy
through focused initiatives that leverage big data, including
XiFin’s Payor Rate Transparency Monitor and Lab Volume Index.
Who:
Featured XiFin speakers at this conference
include:
- Keynote: Big Changes in Healthcare: New Regulations and New
Diagnostics Players Poised to Reshape Lab Testing - Executive
Chair and Chief Executive Officer Lâle White
- Panel: Timing and Implications of FDA LDT Rule; Reforms to
CLIA Regulations; Wider Use of Z-Code by Payers -
Executive Chair and Chief Executive Officer Lâle White
- Latest Trends in Managing Denials and Appeals of Clinical
Lab and Pathology Claims - Senior Director, Pathology
and Strategic Development, Diana Richard and Associate Vice
President, RCM Systems and Analytics, Stephanie Denham
- How AI Is Reshaping Revenue Cycle Management -
Senior Vice President, Engineering and Analytics, Jeff Carmichael
and Vice President, Product and Partner Marketing, Sandra
Greefkes
- Panel: Developing and Enhancing Win/Win Relationships That
Add Value to Key Payers and Health Plans in Your Region
- Senior Director, Revenue and Payor Optimization, Clarisa
Blattner
- Expanding Your Lab’s Market Access: Leveraging Existing
Contracts to Increase Covered Testing Services, Gain Provider
Status with New Payers, and Negotiate More Reimbursement - Vice
President and Head of Specialty RCM, Heather Agostinelli, Senior
Director of Revenue and Payor Optimization, Clarisa Blattner, and
strategic partner and industry expert on market access, Debbie
Windsor
When:
April 29th – May 1st, 2024
Where:
Hyatt Regency New Orleans
601 Loyola Ave, New Orleans, LA 70113
Contact:
Audrey Chang (202) 489-8634 or
a.chang@togorun.com
About XiFin
XiFin is a healthcare information technology company that
empowers healthcare organizations to navigate an increasingly
complex and evolving healthcare landscape. Through innovative
AI-enabled technologies and services, we deliver operational
efficiency, interoperability, and simplicity. The company’s revenue
cycle management, clinical workflow enablement, laboratory
information system, and patient engagement solutions enable
organizations to achieve stronger finances, streamline operations,
and develop industry-leading business strategies. XiFin solutions
deliver THE POWER TO DO GOOD™ so that healthcare organizations can
do more good for more patients. Visit www.XiFin.com, follow XiFin
on LinkedIn, or subscribe to the XiFin blog to learn more.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240423862318/en/
Audrey Chang (202) 489-8634 a.chang@togorun.com